CORY RICE: Open Payments
NPI 1336610450 · DRAPER, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,380 in 79 payments from 25 companies in 2025. Trend: 2023 $1,315 · 2024 $1,092 · 2025 $1,380
Food & beverage: $1,380
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $366 |
| Corcept Therapeutics | 8 | $165 |
| AstraZeneca Pharmaceuticals LP | 6 | $97 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $86 |
| Lilly USA, LLC | 4 | $67 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $67 |
| PFIZER INC. | 4 | $60 |
| Novo Nordisk Inc | 3 | $53 |
| Exact Sciences Corporation | 3 | $49 |
| Tris Pharma Inc | 2 | $34 |
Products named: VRAYLAR, Korlym, QULIPTA, CAPLYTA, TRINTELLIX, FARXIGA, Cologuard Collection Kit, UBRELVY.
Industry payments across UT — which companies pay providers there.
